Cas:18886-16-3 disodium 7-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-[(2-sulphonatophenyl)azo]naphthalene-2-sulphonate manufacturer & supplier

Chemical Name:disodium 7-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-[(2-sulphonatophenyl)azo]naphthalene-2-sulphonate

CAS.NO:18886-16-3

Synonyms:2-naphthalenesulfonic acid,7-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-4-hydrox;C.I. Reactive orange 1;Reactive Orange X-G

Molecular Formula:C₁₉H₁₀Cl₂N₆Na₂O₇S₂

Molecular Weight:615.33400

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:226.81000

Exact Mass:613.92200

LogP:6.23900

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-naphthalenesulfonic acid,7-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-4-hydrox chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Reactive Orange X-G physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-naphthalenesulfonic acid,7-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-4-hydrox Use and application,2-naphthalenesulfonic acid,7-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-4-hydrox technical grade,usp/ep/jp grade.

Related News: We partner with life science companies of all sizes, drawing on over 20 years of industry experience. disodium 7-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-[(2-sulphonatophenyl)azo]naphthalene-2-sulphonate manufacturer In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase. disodium 7-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-[(2-sulphonatophenyl)azo]naphthalene-2-sulphonate supplier We partner with life science companies of all sizes, drawing on over 20 years of industry experience. disodium 7-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-[(2-sulphonatophenyl)azo]naphthalene-2-sulphonate vendor China has granted conditional approval to its first self-developed treatment for Alzheimer��s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug. disodium 7-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-[(2-sulphonatophenyl)azo]naphthalene-2-sulphonate factory In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase.